Let's take a look at a headline out of Australia because there are some unknowns in this headline that we did some digging on and found some more unknowns.

So out of Australia, they scrapped their vaccine program. So Australia drops promising COVID-19 vaccine after volunteers falsely tested positive for HIV.

So the article goes and says the Australian government has abandoned a promising domestic COVID-19 vaccine developed by the University of Queensland and biotech firm CSL after participants in an early stage clinical trial falsely tested positive for HIV.

University of Queensland said significant changes would be would need to be made to well establish HIV testing procedures in the healthcare setting to accommodate the rollout of this vaccine.

When I read that, I thought you're going to have to change the testing procedures because it's getting back to the screen.

It screams baloney beans everybody. I mean, if you read these things ago, oh, okay, by the way, they invested $750 million into this vaccine program and they're just tossing it in the way it's been because it causes, you know, false, false positives.

Nobody's getting rid of something because it causes a false positive. You can read something because there is a real problem. There must be a real problem.

We're not being told about least that's where my brain goes. I'm sorry. May, may I'm skeptical. Maybe I've just lost all trust in humanity, but I've definitely lost all trust in health departments and the pharmaceutical industry.

So prove to me otherwise. I'm guessing there's a bigger problem. Yeah, and you know, it's arguably there's a lot of good data that the PCR tests used from our data and visors experiments, vaccines were causing false positives.

And that's what we had. Right.

We're getting old. I'm anyway. So the Queensland vaccine. This is out of the guardian headline here. And I started to piece this together and just want to take you on a little journey of a possible situation.

In this article, it says the researchers also found the vaccine generated antibodies toward the, towards the molecular clamp, which led to a false positive result when participants were tested for HIV.

So now we were introduced with this word called molecular clamp. So looking into this little further, we look looked at first some studies on this. And this is what I found.

So the first study we're going to look at it's titled rapid response sub unit vaccine design, the absence of structural information. The research of this paper, they're funded by sepi that's collision for epidemic preparedness innovations as the gates connection.

And they were looking for a pipeline for a quick vaccine development using a proprietary molecular clamp platform.

And what they found and what is being used in the Queensland University of Queensland vaccine is this in that article it quotes and this gets into the science a little bit, but it's important.

The molecular clamp is a trimurization motive of 80 amino acid in length derived from N and C terminal haptad repeat regions of HIV 1 GP 41 that's like a protein 41. Remember that.

Which self assemble into a stable six helical bundle structure that is critical for driving membrane fusion and cell entry.

Now we go over to the University of Minnesota. They have a paper where they talk about this HIV glycoprotein.

Their papers title activation of human microglio cells by HIV dash one GP 41 and TAT proteins. What they say is they found the HIV one dash one proteins TAT and GP 41 have been detected in the brains of demanded patients at post mortem examination.

The levels of these viral proteins appear to correlate with the severity of the CNS disease both TAT and GP 41 have been found to be neurotoxic.

So now we're having a situation here where where are these where are these molecular clamps going and I want to say like we're throwing a lot of letters CNS essential nervous system now remember remember about the central nervous system the nervous system and all these things when we hear about you know whether transverse myelitis the neurons all of these things are involved in these trials.

...